The invention discloses a kind of compound telithromycin nanoemulsion oral liquid the particle diameter of this oral liquid is 1～100nm raw material by following mass percent is made: surfactant 35%～45% cosurfactant 1%～5% oil phase 4%～12% Ketek 1%～3.5% Bisolvon 0.1%～0.3% surplus are deionized water and the mass percent sum of above-mentioned raw materials is 100%.Ketek is that first is also the ketolide medicine of an at present only listing in the world have broad spectrum antibiotic activity lower selection drug resistance and with the cross resistance of other ketone antibiotics; With after itself and Bisolvon compatibility demonstrated powerful therapeutic effect in the treatment to respiratory tract infection.Compound nanometer emulsion of the present invention has significantly improved the activity of two kinds of medicines and is safe and preparation is simple and energy consumption is low does not need special installation to produce in a large number at field of medicaments wide market prospect is arranged.

暂无附图